Format

Send to

Choose Destination
Bioorg Med Chem Lett. 2002 Aug 5;12(15):2019-22.

2-(2-Hydroxy-3-alkoxyphenyl)-1H-benzimidazole-5-carboxamidine derivatives as potent and selective urokinase-type plasminogen activator inhibitors.

Author information

1
Celera, 180 Kimball Way, South San Francisco, CA 94080, USA.

Abstract

The development of potent and selective urokinase-type plasminogen activator (uPA) inhibitors based on the lead molecule 2-(2-hydroxy-3-ethoxyphenyl)-1H-benzimidazole-5-carboxamidine (3a) is described.

PMID:
12113832
DOI:
10.1016/s0960-894x(02)00311-6
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center